Salinomycin


Home Where It Comes From Current Uses
Promises Downsides Research

Research into Salinomycin

Tumor acidosis enhances cytotoxic effects and autophagy inhibition by salinomycin on cancer cell lines and cancer stem cells

Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via inhibition of STAT3 activation in triple-negative breast cancer cells

Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases

Low-dose salinomycin induces anti-leukemic responses in AML and MLL.

Salinomycin induced ROS results in abortive autophagy and leads to regulated necrosis in glioblastoma

Glucose starvation-mediated inhibition of autophagy amplifies cancer cell specific cell death induction by Salinomycin

Salinomycin and other ionophores as new class of antimalarial drugs with transmission blocking activity

Geno- and cytotoxicity of salinomycin in human nasal mucosa and peripheral blood lymphocytes

Salinomycin and Other Polyether Ionophores Are a New Class of Antiscarring Agent*

Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells

Cancer and cancer stem cell targeting agents : A focus on salinomycin and apoptin

 

 

Home Where It Comes From Current Uses
Promises Downsides Research
About This Website Privacy Policy